Toxicity study of Korean ginseng herbal medicine

Research Journal of Pharmacology

Volumn 4, Issue 4, 2010, Pages 86-90

  Gadkariem, E A ^a   Al Ashban, R M ^b   Babikir, L B ^b   Al Joher, H I ^b  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b Food and Drug Authority   (Saudi Arabia)

Author keywords

Acute; Chronic toxicity; Hemoglobin; Korean ginseng; RBC; Sub acute

Indexed keywords

GLUCOSE; HEMOGLOBIN; HERBACEOUS AGENT;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC TOXICITY; CONTROLLED STUDY; DOSE RESPONSE; ERYTHROCYTE; FEMALE; GENOTOXICITY; GINSENG; GLUCOSE BLOOD LEVEL; HERBAL MEDICINE; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; SINGLE DRUG DOSE; TOXICITY TESTING;

EID: 79951564931     PISSN: 18159362     EISSN: None     Source Type: Journal    
DOI: 10.3923/rjpharm.2010.86.90     Document Type: Article

References (23)

1. Adamson, J.W., 1980. Dyserythropoietic Anemias. In: Hematology and Oncology, Lichtman, M.A. (Ed.). Vol. 6, Grune and Stratton, New York, pp: 44-45.
2. Al-Harbi, M.M., S. Qureshi, M.M. Ahmed, S. Rafatullah and A.H. Shah, 1994. Effect of commiphora molmol (aloe-gum-resin) on cytological and chemical changes induced by cyclophophamide in mice. Am. J. Chinese Med., 32: 77-82.
3. Attele, A.S., J.A. Wu and C.S. Yuan, 1999. Ginseng pharmacology: Multiple constituents and multiple actions. Biochem. Pharmacol., 58: 1685-1693.
4. Bucci, L.R., 2000. Selected herbals and human exercise performance. Am. J. Clin. Nutr., 72: 624S-636S.
5. Chan, P.K., G.P. O'Hara and A.W. Hayes, 1982. Principles and Methods of Acute and Sub-Chronic Toxicity. In: Principles and Methods of Toxicology, Hayes, A.W. (Ed.). Raven Press, New York, ISBN: 0890044708, pp:l-51.
6. Chang, Y.S., E.K. Seo, C. Gyllenhaal and K.I. Block, 2003. Panax ginseng: A role in cancer therapy. Integr. Cancer Ther., 2: 13-33.
7. Huang, Y.C., C.T. Chen, S.C. Chen, P.H. Lai and H.C. Liang et at, 2005. A natural compound (Ginsenoside Re) isolated from Panax ginseng as a novel angiogenic agent for tissue regeneration. Pharmaceutical Res., 22: 636-646.
8. Joo, S.S., T.J. Won and ID. Lee, 2005. Reciprocal activity of ginsenosides in the production of proinflammatory repertoire and their potential roles in neuroprotection invivo. PlantaMed., 71: 476-481.
9. Jung, C.H., H.M. Seog, I.W. Choi, H.D. Choi and H.Y. Cho, 2005. Effects of wild ginseng (Panax ginseng C.A. Meyer) leaves on lipid peroxidation levels and antioxidant enzyme activities in streptozotocin diabetic rats. J. Ethnopharmacol., 98: 245-250.
10. Kiefer, D. and T. Pantuso, 2004. Panax ginseng. Am. Fam. Physician., 70: 1231-1231.
11. Mcelhaney, J.E., S. Gravenstein, S.K. Cole, E. Davidson and D. O'neill et al., 2004. A placebo-controlled trial of a proprietary extract of North American ginseng (CVT-E002) to prevent acute respiratory illness in institutionalized older adults. J. Am. Geriatrics Soc, 52: 13-19.
12. Mossberg, A.T. and A.W. Hayes, 1989. Sub-chronic Toxicity Testing. In: Principles and Methods of Toxicology, Hayes, A.W. (Ed.). 2nd Edn., Raven Press, New York, pp: 221-236.
13. Nishino, H., H. Tokuda, T. Ii, M. Takemura and M. Kuchide et al., 2001. Cancer chemoprevention by ginseng in mouse liver and other organs. J. Korean Med. Sci., 16: S66-S69.
14. Qureshi, S., A.H. Shah and A.M. Aqeel, 1992. Toxicity studies on Alpinia galanga and Curcuma longa. PlantaMed., 58: 124-127.
15. Robin, J.F., J.J. Jomer and RR. Schueler, 1982. Methods in Testing for Carcinogenicity. In: Principles and Methods of Toxicology, Raven, A.W.H. (Ed.). 1st Edn., Raven Press, New York, pp: 79-105.
16. Sengupta, S., S.A. Toh, L.A. Sellers, J.N. Skepper and P. Koolwijk, 2004. Modulating angiogenesis: The yin andtheyang in ginseng. Circulation, 110: 1219-1225.
17. Shen, L., J.Z. Han, C. Li, S.J. Yue and Y. Liu, 2007. Protective effect of ginsenoside Rgl on glutamate-induced lung injury. Acta Pharmacol. Smica, 28: 392-397.
18. Shin, H.R., J. Y. Kim, T.K. Yun, G. Morgan and H. Vainio, 2000. The cancer preventive potential of Panax ginseng: A review of human and experimental evidence. Cancer Causes Control, 11: 565-576.
19. Sotaniemi, E.A., E. Haapakoski and A. Rautio, 1995. Ginseng therapy in non-insulin-dependent diabetic patients. Diabetes Care, 18: 1373-1375.
20. Tsang, D., H.W. Yeung, W.W. Tso and H. Peck, 1985. Ginseng saponins: Influence on neurotransmitter uptake in rat brain synaptosomes. PlantaMed., 51: 221-224.
21. Wang, Z., Q. Zheng, K. Liu, G. Li and R. Zheng, 2006. Ginsenoside Rh2 enhances antitumour activity and decreases genotoxic effect of cyclophosphamide. Basic Clin. Pharmacol. Toxicol., 98: 411-415.
22. Yun, T.K., S.Y. Choi and H.Y. Yun, 2001. Epidemiological study on cancer prevention by ginseng: Are all kinds of cancers preventable by ginseng. J. Korean Med. Sci., 16: S19-S27.
23. Zhang, D., T. Yasuda, Y. Yu, P. Zheng, T. Kawabata, Y. Ma and S. Okada, 1996. Ginseng extract scavenges hydroxyl radical and protects unsaturated fatty acids from decomposition caused by iron-mediated lipid peroxidation Free Radic. Biol. Med., 20: 145-150.